Pages that link to "Q43284592"
Jump to navigation
Jump to search
The following pages link to Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide (Q43284592):
Displaying 31 items.
- Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study (Q28660810) (← links)
- A Practical Review of C-Peptide Testing in Diabetes (Q33732640) (← links)
- Significance of plasma C-peptide in obese African American adolescents (Q33821245) (← links)
- Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes. (Q34131203) (← links)
- Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin (Q34297738) (← links)
- Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes (Q34507037) (← links)
- Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes (Q34583267) (← links)
- C-Peptide and vascular complications in type 2 diabetic subjects (Q36365226) (← links)
- Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis (Q36818151) (← links)
- The clinical utility of C-peptide measurement in the care of patients with diabetes (Q37108880) (← links)
- Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. (Q37246676) (← links)
- The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells (Q37374229) (← links)
- Urinary C peptide creatinine ratio in pregnant women with normal glucose tolerance and type 1 diabetes: evidence for insulin secretion (Q37576692) (← links)
- Urinary C-peptide analysis in an intervention study: experience from the DEFEND-2 otelixizumab trial (Q38811287) (← links)
- Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic. (Q41251582) (← links)
- Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients (Q41513696) (← links)
- Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors (Q42380027) (← links)
- Possible influence of ileal neobladder on assessment of urinary C-peptide (Q43061069) (← links)
- Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes. (Q47579527) (← links)
- Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes (Q50489551) (← links)
- Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes. (Q51280338) (← links)
- Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes (Q51368838) (← links)
- Detection of C-Peptide in Urine as a Measure of Ongoing Beta Cell Function. (Q52874770) (← links)
- Insulin sensitivity assessed using urine C peptide creatinine ratio (UCPCR) in pregnancy: cross-sectional analysis of an English multiethnic cohort. (Q53826099) (← links)
- The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study. (Q54580077) (← links)
- Tests aiding diagnosis of monogenic diabetes (Q57917247) (← links)
- Stability of urinary albumin and creatinine after 12 months storage at -20 °C and -80 °C (Q64063646) (← links)
- Urinary C-Peptide Creatinine Ratio as a Non-Invasive Tool for Identifying Latent Autoimmune Diabetes in Adults (LADA) (Q91829605) (← links)
- Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes (Q92787276) (← links)
- Clinical Implications of Urinary C-Peptide Creatinine Ratio in Patients with Different Types of Diabetes (Q93110072) (← links)
- Update on clinical screening of maturity-onset diabetes of the young (MODY) (Q96303797) (← links)